INTERNATIONAL PATENT: ARVINAS OPERATIONS, INC., NOVARTIS AG, PAGANI, SANDRO, LANGE, JUSTUS JOHANN, PORFIRIO FONSECA, TIAGO, CHABAUD, SEBASTIEN, BOUILLOT, PHILIPPE MICHEL RENE FILES APPLICATION FOR "PHARMACEUTICAL FORMULATIONS OF AN ANDROGEN RECEPTOR-TARGETING PROTEIN DEGRADER"

GENEVA, Nov. 5 -- ARVINAS OPERATIONS, INC. (5 Science Park395 Winchester AveNew Haven, Connecticut 06511), NOVARTIS AG (Lichtstrasse 354056 Basel), PAGANI, Sandro (c/o Novartis AGLichtstrasse 354056 Basel), LANGE, Justus Johann (c/o Novartis AGLichtstrasse 354056 Basel), PORFIRIO FONSECA, Tiago (c/o Novartis AGLichtstrasse 354056 Basel), CHABAUD, Sebastien (c/o Novartis AGLichtstrasse 354056 Basel), BOUILLOT, Philippe Michel Rene (c/o Novartis AGLichtstrasse 354056 Basel) filed a patent application (PCT/US2025/026253) for "PHARMACEUTICAL FORMULATIONS OF AN ANDROGEN RECEPTOR-TARGETING PROTEIN DEGRADER" on Apr 24, 2025. With publication no. WO/2025/226973, the details related to the patent application was published on Oct 30, 2025.

Notably, ...